Develops ultrafiltration systems for fluid overload in heart failure patients.
Jun 2026Revenue $9.01M/yrExpenses $21.9M/yr
No trendCash runway ≈ 4 months from Jun 2026
Figures by year
When will Nuwellis be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $9.01M and expenses $21.9M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $8.27M | $19.4M | −$11.1M |
| Dec 2024 | $8.74M | $19.7M | −$11.0M |
| Dec 2023 | $8.86M | $26.5M | −$17.6M |
| Dec 2022 | $8.54M | $25.7M | −$17.2M |
| Dec 2021 | $7.92M | $27.4M | −$19.5M |
| Dec 2020 | $7.44M | $24.5M | −$17.0M |
| Dec 2019 | $5.51M | $23.6M | −$18.1M |
| Dec 2018 | $5.00M | $22.0M | −$17.0M |
| Dec 2017 | $3.55M | $18.4M | −$14.8M |
| Dec 2016 | $1.29M | $17.0M | −$15.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.